# Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

> **NCT02125136** · PHASE2 · COMPLETED · sponsor: **AIO-Studien-gGmbH** · enrollment: 168 (estimated)

## Conditions studied

- Ductal Adenocarcinoma of the Pancreas

## Interventions

- **DRUG:** Gem/nab-Pac
- **DRUG:** FOLFIFINOX

## Key facts

- **NCT ID:** NCT02125136
- **Lead sponsor:** AIO-Studien-gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2019-03-01
- **Final completion:** 2020-02-19
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2021-12-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02125136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02125136, "Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02125136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*